Literature DB >> 35245476

The RTS,S vaccine-a chance to regain the upper hand against malaria?

Photini Sinnis1, David A Fidock2.   

Abstract

Malaria is estimated by the World Health Organization (WHO) to have killed 627,000 individuals worldwide in 2020, with nearly 80% of deaths in African children younger than five. The recent WHO approval of the RTS,S/AS01 vaccine, which targets Plasmodium falciparum pre-erythrocytic stages, provides hope that its use combined with other interventions can help reverse the current malaria resurgence.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35245476     DOI: 10.1016/j.cell.2022.01.028

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  2 in total

1.  Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers.

Authors:  Habeebullah Jayeola Oladipo; Yusuf Amuda Tajudeen; Iyiola Olatunji Oladunjoye; Sodiq Inaolaji Yusuff; Rashidat Onyinoyi Yusuf; Egbewande Muyiwa Oluwaseyi; Muili Opeyemi AbdulBasit; Yusuff Adebayo Adebisi; Mona Said El-Sherbini
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

2.  Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.

Authors:  Kuang-Ting Ko; Frank Lennartz; David Mekhaiel; Bora Guloglu; Arianna Marini; Danielle J Deuker; Carole A Long; Matthijs M Jore; Kazutoyo Miura; Sumi Biswas; Matthew K Higgins
Journal:  Nat Commun       Date:  2022-09-24       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.